Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are reiterating our recommendation on the shares of Aetna Inc. (AET - Analyst Report) at ‘Neutral’ prior to its third quarter earnings release.
 
We expect Aetna to continue performing favorably over the long term. The company has made considerable investments in products and technology, with an intention to extend its core health business and capitalize on exciting new consumer and provider opportunities, which are emerging in the marketplace. Aetna's strong operating results and significant capital generation will enable it to make further investments.
 
The company has announced to acquire Coventry Health Care Inc., which will deepen its footprint in the Medicare market. The acquisition is also expected to be immediately accretive to earnings.
 
Aetna is also aiming at generating incremental fee revenues by managing infrastructure required for care organizations.
 
With respect to Aetna’s international business, the product launches in China, earlier during the year, met with initial success. The company also entered the Indian market with the acquisition of the Indian Health Organization. These are indicative of Aetna’s efforts to expand its global footprint and develop new business models.
 
Aetna has made a number of acquisitions in its Commercial business such as Prodigy. Prodigy's highly-customized offering addresses a portion of the self-funded market, covering approximately 27 million individuals. Additionally, the company acquired PayFlex, an administrator of Flexible Spending Accounts (FSAs), Health Savings Accounts (HSAs) and other accounts that support consumer-based health plan designs.
 
Aetna’s balance sheet is quite strong with moderate leverage. Its excess cash generation in 2011 enabled it to complete four significant acquisitions, repurchase 45 million shares and institute a meaningful shareholder dividend.
 
However, membership growth, restriction on premium rate increase, an increase in medical costs expected in 2012 and a low interest rate environment are some of the headwinds, which the company is facing at this moment.
 
Aetna currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Some of its peers within our coverage, who also retain a Zacks #3 Rank and a long-term Neutral recommendation, include CIGNA Corp. (CI - Analyst Report) and WellPoint Inc. (WLP - Analyst Report).  
We are reiterating our recommendation on the shares of Aetna Inc. (AET - Analyst Report) at Neutral prior to its third quarter earnings release.
 
We expect Aetna to continue performing favorably over the long term. The company has made considerable investments in products and technology, with an intention to extend its core health business and capitalize on exciting new consumer and provider opportunities, which are emerging in the marketplace. Aetna's strong operating results and significant capital generation will enable it to make further investments.
 
The company has announced it will acquire Coventry Health Care Inc., which will deepen its footprint in the Medicare market. The acquisition is also expected to be immediately accretive to earnings.
 
Aetna is also aiming at generating incremental fee revenues by managing infrastructure required for care organizations.
 
With respect to Aetna’s international business, the product launches in China, earlier during the year, met with initial success. The company also entered the Indian market with the acquisition of the Indian Health Organization. These are indicative of Aetna’s efforts to expand its global footprint and develop new business models.
 
Aetna has made a number of acquisitions in its Commercial business such as Prodigy. Prodigy's highly-customized offering addresses a portion of the self-funded market, covering approximately 27 million individuals. Additionally, the company acquired PayFlex, an administrator of Flexible Spending Accounts (FSAs), Health Savings Accounts (HSAs) and other accounts that support consumer-based health plan designs.
 
Aetna’s balance sheet is quite strong with moderate leverage. Its excess cash generation in 2011 enabled it to complete four significant acquisitions, repurchase 45 million shares and institute a meaningful shareholder dividend.
 
However, membership growth, restriction on premium rate increase, an increase in medical costs expected in 2012 and a low interest rate environment are some of the headwinds, which the company is facing at this moment.
 
Aetna currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Some of its peers within our coverage, who also retain a Zacks #3 Rank and a long-term Neutral recommendation, include CIGNA Corp. (CI - Analyst Report) and WellPoint Inc. (WLP - Analyst Report).  

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%